CompletedPhase 4

Persistence of Immune Response After Vaccination With MCC

United Kingdom1,244 participantsStarted 2004-10

Plain-language summary

Persistence of Immune response after vaccination with MCC

Who can participate

Age range11 Years – 20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * healthy adolescents vaccinated with Meningococcal C Conjugate vaccine Exclusion Criteria: * ascertained or suspected disease caused by N. meningitidis * household contact with individuals with proven N. meningitidis serogroup C infection * significant acute or chronic infections * any other serious disease

What they're measuring

persistence of memory response to N. meningitidis serogroup C as measured by serum bactericidal activity at one year after either a challenge with 1/5 of a dose of Meningococcal A/C Polysaccharide vaccine or a booster dose of MenC Vaccine.

Trial details

NCT IDNCT00310687

SponsorNovartis

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2005-12

View on ClinicalTrials.gov More Prevention of Meningococcal Infection trials